Lymphocytoplasmapheresis in multiple sclerosis: preliminary laboratory findings.
Short-term treatment with lymphocytoplasmapheresis was evaluated in 6 multiple sclerosis patients with special reference to the electrophysiological and immunological findings. Visual, somatosensory, brainstem auditory evoked potentials, flicker fusion test, helper/suppressor blood lymphocyte ratio, serum immunocomplexes and immunoglobulins and Kurtzke scores were evaluated in each patient before and after treatment. No statistically significant results were obtained.
D000328:Adult; D005071:Evoked Potentials; D005260:Female; D005425:Flicker Fusion; D006801:Humans; D008214:Lymphocytes; D008297:Male; D009103:Multiple Sclerosis / Q000628:therapy*; D010956:Plasmapheresis